Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...
If you think you may have geographic atrophy (GA), your eye doctor can run tests and do an exam to find out. Here’s what to look for and how to find out if you have it. If you have an advanced stage ...
Geographic atrophy (GA), the late stage of age-related macular degeneration (AMD), may lead to vision loss. Here’s what to expect as the condition progresses. About 1 million people in the United ...
While there is currently no cure for geographic atrophy, certain treatments, such as complement inhibitors, can help slow its progression by targeting immune system activity that damages the macula.
A novel outcome measure for geographic atrophy, the Geographic Atrophy Weighted-by-Acuity Index, aligned with best-corrected visual acuity, showing better correlation and predictive accuracy than the ...
Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...
Take these precautions to protect your eye health and preserve your vision. “Geographic atrophy is the thinning or the loss of tissue. Like how muscles atrophy and get thinner and weaker, the same ...
Learning to adapt to life with geographic atrophy (GA), one woman finds new ways to stay true to her adventurous spirit ...
Please provide your email address to receive an email when new articles are posted on . Another landmark moment in eye care occurred this year with the approval of pegcetacoplan, known as Syfovre from ...
Geographic atrophy (GA) is one of two kinds of advanced age-related macular degeneration (AMD). It’s an eye disease that damages cells in the central part of your retina called the macula. Late-stage ...
Ryan Haumschild, PharmD, MS, MBA, opens a discussion surrounding the disease landscape of geographic atrophy. Ryan Haumschild, PharmD, MS, MBA: Hello, and welcome to this AJMC® Peer Exchange®program ...